Analystreport

Verona Pharma plc (NASDAQ: VRNA) had its price target lowered by analysts at Wedbush from $25.00 to $18.00.

Verona Pharma plc - American Depositary Shares  (VRNA) 
US:NASDAQ Investor Relations: nasdaq.com/symbol/vrna/real-time